Corrigendum to “New insights into long non-coding RNAs in non-small cell lung cancer” [Biomed. Pharmacother. 131 (November) (2020) 110775]

Corrigendum to “New insights into long non-coding RNAs in non-small cell lung cancer” [Biomed. Pharmacother. 131 (November) (2020) 110775]

Bibliographic Details
Main Authors:	Ruifang Ye, Ruixiang Tang, Siyuan Gan, Rujia Li, Ying Cheng, Linlang Guo, Yanqin Sun, Chao Zeng
Format:	Article
Language:	English
Published:	Elsevier 2020-12-01
Series:	Biomedicine & Pharmacotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S0753332220311227

Similar Items

New insights into long non-coding RNAs in non-small cell lung cancer
by: Ruifang Ye, et al.
Published: (2020-11-01)

Corrigendum to “Umbelliferone (7-hydroxycoumarin): A non-toxic antidiarrheal and antiulcerogenic coumarin” [Biomed. Pharmacother. 129 (2020) 110432]
by: Luisa Ferreira da Cruz, et al.
Published: (2020-10-01)

Corrigendum to “Prolyl oligopeptidase inhibition by KYP-2407 increases alpha-synuclein fibril degradation in neuron-like cells” [Biomed. Pharmacother. 131 (2020) 110788]
by: Jinar Rostami, et al.
Published: (2021-01-01)

Corrigendum to “Dysbiosis of gut microbiota is associated with gastric carcinogenesis in rats” [Biomed Pharmacother. 126 (2020) 110036]
by: Chunyue Yu, et al.
Published: (2020-08-01)

Corrigendum to “Nucleosome binding peptide presents laudable biophysical and in vivo effects” [Biomed. Pharmacother. 121 (2020) 109678]
by: Kaian Teles, et al.
Published: (2020-03-01)

Corrigendum to “Exosomes: An emerging factor in atherosclerosis” [Biomed. Pharmacother. 115 (2019) 108951]
by: Yanan Wang, et al.
Published: (2019-10-01)

Corrigendum to “Nrf2 transcriptional activity in the mouse affects the physiological response to tribromoethanol” [Biomed. Pharmacother. 128 (2020) 110317]
by: Aleksandra Kopacz, et al.
Published: (2021-01-01)

Corrigendum to ‘Innovated formulation of TCM pangolin scales to develop a nova therapy of rheumatoid arthritis’ [Biomed. Pharmacother. 126 (2020) 109872]
by: Huiqing Lv, et al.
Published: (2021-08-01)

Corrigendum to “Luteolin, a flavonoid, as an anticancer agent: A review” [Biomed. Pharmacother. 112 (2019) 108612]
by: Muhammad Imran, et al.
Published: (2019-08-01)

Corrigendum to “Berberine associated photodynamic therapy promotes autophagy and apoptosis via ROS generation in renal carcinoma cells” [Biomed. Pharmacother. 123 (2020) 109794]
by: Tairine Zara Lopes, et al.
Published: (2021-04-01)

Corrigendum to “Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration” [Biomed. Pharmacother. 128 (2020) 110366]
by: Yangyang Guo, et al.
Published: (2020-09-01)

Corrigendum to “Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration” [Biomed. Pharmacother. 2020 (128) 110366]
by: Yangyang Guo, et al.
Published: (2020-10-01)

Corrigendum to “Berberine associated photodynamic therapy promotes autophagy and apoptosis via ROS generation in renal carcinoma cells” [Biomed. Pharmacother., v.123 (2020) 109794]
by: Tairine Zara Lopes, et al.
Published: (2020-05-01)

Corrigendum to “Ginsenoside Rd contributes the attenuation of cardiac hypertrophy in vivo and in vitro” [Biomed. Pharmacother. 109 (2019) 1016–1023]
by: Ningning Zhang, et al.
Published: (2020-10-01)

Corrigendum to: “Novel and emerging mutations of SARS-CoV-2: Biomedical implications” [Biomed. Pharmacother. 139 (2021) 111599]
by: Elmira Mohammadi, et al.
Published: (2021-08-01)

Corrigendum to ‘Physiological and pathophysiological roles of Acidic mammalian chitinase (CHIA) in multiple organs’ [Biomed. Pharmacother. 138 (2021) 111465]
by: Chunli Hu, et al.
Published: (2021-07-01)

Corrigendum to “GJ-4 alleviates Aβ25-35-induced memory dysfunction in mice through protecting the neurovascular unit” [Biomed. Pharmacother. 127 (2020) 110131]
by: Zihong Zhang, et al.
Published: (2020-08-01)

Corrigendum to “SNHG11 contributes to NSCLC cell growth and migration by targeting miR-485-5p/BSG axis” [Biomed. Pharmacother. 128 (2020) 110324]
by: Ruirui Cheng, et al.
Published: (2020-12-01)

Corrigendum to ‘Effects of curcumin based PDT on the viability and the organization of actin in melanotic (A375) and amelanotic melanoma (C32) – in vitro studies’ [Biomed. Pharmacother. 132 (2020) 110883]
by: Wojciech Szlasa, et al.
Published: (2021-07-01)

Corrigendum to “Saikosaponin A inhibits the activation of pancreatic stellate cells by suppressing autophagy and the NLRP3 inflammasome via the AMPK/mTOR pathway” [Biomed. Pharmacother. 128 (2020) 110216]
by: Lihua Cui, et al.
Published: (2020-10-01)

Corrigendum to “CCT128930 induces G1-phase arrest and apoptosis and synergistically enhances the anticancer efficiency of VS5584 in human osteosarcoma cells” [Biomed. Pharmacother. 130 (2020) 110544]
by: Jing-yi Sun, et al.
Published: (2020-12-01)

Corrigendum to “Chrysin-nanoencapsulated PLGA-PEG for macrophage repolarization: Possible application in tissue regeneration” [Biomed. Pharmacother. 105 (2018) 773–780]
by: Akram Firouzi-Amandi, et al.
Published: (2019-10-01)

Corrigendum to “Pro-apoptotic effects of Amblyomin-X in murine renal cell carcinoma “in vitro” [Biomed. Pharmacother. 66 (2012) 64–69]
by: Erica Mie Akagi, et al.
Published: (2019-10-01)

Corrigendum to “Study on the efficacy and mechanism of triptolide on treating TNF transgenic mice with rheumatoid arthritis” [Biomed. Pharmacother. 106 (2018) 813–820]
by: Shengli Wang, et al.
Published: (2019-03-01)

Corrigendum to “Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer” [Biomed Pharmacother. 97 (2018) 1275–1281]
by: Jiali Wu, et al.
Published: (2020-07-01)

Corrigendum to “Ischemic postconditioning exerts neuroprotective effect through negatively regulating PI3K/Akt2 signaling pathway by microRNA-124” [Biomed. Pharmacother. 126 (2020) 109786]
by: Wei Miao, et al.
Published: (2020-09-01)

Corrigendum to “Raw and salt-processed Achyranthes bidentata attenuate LPS-induced acute kidney injury by inhibiting ROS and apoptosis via an estrogen-like pathway [Biomed. Pharmacother. 129 (2020) 110403]”
by: Shengchao Wang, et al.
Published: (2021-09-01)

Corrigendum to “SiNiSan ameliorates depression-like behavior in rats by enhancing synaptic plasticity via the CaSR-PKC-ERK signaling pathway” [Biomed. Pharmacother. 124 (2020) 109787]
by: Chongkun Shen, et al.
Published: (2021-01-01)

Corrigendum to “Ac2-26 ameliorates lung ischemia-reperfusion injury via the eNOS pathway” [Biomed. Pharmacother. 117 (2019) 109194]
by: Jing Gong, et al.
Published: (2020-10-01)

Corrigendum to “Intrinsic β-catenin signaling suppresses CD8 + T-cell infiltration in colorectal cancer” [Biomed. Pharmacother. 115 (May) (2019) 108921]
by: Junli Xue, et al.
Published: (2020-12-01)

Corrigendum to “miR-10b promotes invasion by targeting KLF4 in osteosarcoma cells” [Biomed. Pharmacother. 84 (2016) 947–953]
by: Jing Wang, et al.
Published: (2020-08-01)

Corrigendum to “Evaluation of antiviral effect and toxicity of total flavonoids extracted from Robinia pseudoacacia cv. idaho” [Biomed. Pharmacother. 118 (2019) 109335]
by: Hao Guo, et al.
Published: (2020-03-01)

Corrigendum to “IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway” [Biomed. Pharmacother. 123 (2020) 109790]
by: Hongning Cai, et al.
Published: (2020-06-01)

Corrigendum to “Folate inhibits miR-27a-3p expression during cervical carcinoma progression and oncogenic activity in human cervical cancer cells” [Biomed. Pharmacother. 122 (2020) 109654]
by: Zhe Wang, et al.
Published: (2020-05-01)

Corrigendum to “MiR-25-3p promotes malignant phenotypes of retinoblastoma by regulating PTEN/Akt pathway” [Biomed. Pharmacother. 118 (2019) 109111]
by: Wencui Wan, et al.
Published: (2020-11-01)

Corrigendum to ‘Proteomic changes in the hippocampus and motor cortex in a rat model of cerebral palsy: Effects of topical treatment’ [Biomed. Pharmacother. 133 (2021) 110844]
by: Tao Wang, et al.
Published: (2021-08-01)

Corrigendum to “Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice” [Biomed. Pharmacother. 118 (2019) 109206]
by: Qiuke Hou, et al.
Published: (2019-10-01)

Corrigendum to “Huachansu capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway” [Biomed. Pharmacother. 118 (2019) 109241]
by: Tengyang Ni, et al.
Published: (2020-03-01)

Corrigendum to “Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo” [Biomed. Pharmacother. 116 (2019) 109032]
by: Mao-Chi Weng, et al.
Published: (2019-10-01)

Corrigendum to “ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes” [Biomed. Pharmacother. 126 (2020) 110066]
by: X. Li, et al.
Published: (2020-10-01)

Cannot write session to /tmp/vufind_sessions/sess_e07r30t13up36mi3hg8cekh50r